43 related articles for article (PubMed ID: 38699187)
21. Pre-mRNA processing factor 19 functions in DNA damage repair and radioresistance by modulating cyclin D1 in hepatocellular carcinoma.
Yu XN; Zhang GC; Liu HN; Zhu JM; Liu TT; Song GQ; Dong L; Yin J; Shen XZ
Mol Ther Nucleic Acids; 2022 Mar; 27():390-403. PubMed ID: 35036052
[TBL] [Abstract][Full Text] [Related]
22. Low glycaemic diets alter lipid metabolism to influence tumour growth.
Lien EC; Westermark AM; Zhang Y; Yuan C; Li Z; Lau AN; Sapp KM; Wolpin BM; Vander Heiden MG
Nature; 2021 Nov; 599(7884):302-307. PubMed ID: 34671163
[TBL] [Abstract][Full Text] [Related]
23. Metabolomics in cancer research and emerging applications in clinical oncology.
Schmidt DR; Patel R; Kirsch DG; Lewis CA; Vander Heiden MG; Locasale JW
CA Cancer J Clin; 2021 Jul; 71(4):333-358. PubMed ID: 33982817
[TBL] [Abstract][Full Text] [Related]
24. Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma.
Li X; Zhao L; Wei M; Lv J; Sun Y; Shen X; Zhao D; Xue F; Zhang T; Wang J
J Cancer; 2021; 12(11):3190-3197. PubMed ID: 33976728
[No Abstract] [Full Text] [Related]
25. Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning.
Yuan Y; Zhao Z; Xue L; Wang G; Song H; Pang R; Zhou J; Luo J; Song Y; Yin Y
Br J Cancer; 2021 Aug; 125(3):351-357. PubMed ID: 33953345
[TBL] [Abstract][Full Text] [Related]
26. Metabolomics, metabolic flux analysis and cancer pharmacology.
Liang L; Sun F; Wang H; Hu Z
Pharmacol Ther; 2021 Aug; 224():107827. PubMed ID: 33662451
[TBL] [Abstract][Full Text] [Related]
27. Precision screening for esophageal squamous cell carcinoma in China.
He Z; Ke Y
Chin J Cancer Res; 2020 Dec; 32(6):673-682. PubMed ID: 33446991
[TBL] [Abstract][Full Text] [Related]
28. A lipidome atlas in MS-DIAL 4.
Tsugawa H; Ikeda K; Takahashi M; Satoh A; Mori Y; Uchino H; Okahashi N; Yamada Y; Tada I; Bonini P; Higashi Y; Okazaki Y; Zhou Z; Zhu ZJ; Koelmel J; Cajka T; Fiehn O; Saito K; Arita M; Arita M
Nat Biotechnol; 2020 Oct; 38(10):1159-1163. PubMed ID: 32541957
[TBL] [Abstract][Full Text] [Related]
29. Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers.
Zhu ZJ; Qi Z; Zhang J; Xue WH; Li LF; Shen ZB; Li ZY; Yuan YL; Wang WB; Zhao J
J Cancer; 2020; 11(13):3944-3954. PubMed ID: 32328198
[No Abstract] [Full Text] [Related]
30. A systematic review of metabolomic profiling of gastric cancer and esophageal cancer.
Huang S; Guo Y; Li Z; Zhang Y; Zhou T; You W; Pan K; Li W
Cancer Biol Med; 2020 Feb; 17(1):181-198. PubMed ID: 32296585
[No Abstract] [Full Text] [Related]
31. Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer.
Yang Z; Song Z; Chen Z; Guo Z; Jin H; Ding C; Hong Y; Cai Z
J Pharm Biomed Anal; 2020 Feb; 180():113069. PubMed ID: 31884394
[TBL] [Abstract][Full Text] [Related]
32. Clinical and translational advances in esophageal squamous cell carcinoma.
Reichenbach ZW; Murray MG; Saxena R; Farkas D; Karassik EG; Klochkova A; Patel K; Tice C; Hall TM; Gang J; Parkman HP; Ward SJ; Tétreault MP; Whelan KA
Adv Cancer Res; 2019; 144():95-135. PubMed ID: 31349905
[TBL] [Abstract][Full Text] [Related]
33. Screening for esophageal squamous cell carcinoma: recent advances.
Codipilly DC; Qin Y; Dawsey SM; Kisiel J; Topazian M; Ahlquist D; Iyer PG
Gastrointest Endosc; 2018 Sep; 88(3):413-426. PubMed ID: 29709526
[TBL] [Abstract][Full Text] [Related]
34. Applications of metabolomics to study cancer metabolism.
Kaushik AK; DeBerardinis RJ
Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):2-14. PubMed ID: 29702206
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular Event Prediction by Machine Learning: The Multi-Ethnic Study of Atherosclerosis.
Ambale-Venkatesh B; Yang X; Wu CO; Liu K; Hundley WG; McClelland R; Gomes AS; Folsom AR; Shea S; Guallar E; Bluemke DA; Lima JAC
Circ Res; 2017 Oct; 121(9):1092-1101. PubMed ID: 28794054
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China.
Liang H; Fan JH; Qiao YL
Cancer Biol Med; 2017 Feb; 14(1):33-41. PubMed ID: 28443201
[TBL] [Abstract][Full Text] [Related]
37. Machine learning applications in cancer prognosis and prediction.
Kourou K; Exarchos TP; Exarchos KP; Karamouzis MV; Fotiadis DI
Comput Struct Biotechnol J; 2015; 13():8-17. PubMed ID: 25750696
[TBL] [Abstract][Full Text] [Related]
38. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities.
Napier KJ; Scheerer M; Misra S
World J Gastrointest Oncol; 2014 May; 6(5):112-20. PubMed ID: 24834141
[TBL] [Abstract][Full Text] [Related]
39. Plasma-based lipidomics reveals potential diagnostic biomarkers for esophageal squamous cell carcinoma: a retrospective study.
Chen Y; Gu Y; Rong J; Xu L; Huang X; Zhu J; Chen Z; Mao W
PeerJ; 2024; 12():e17272. PubMed ID: 38699187
[TBL] [Abstract][Full Text] [Related]
40. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
